Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Endocardial ablation can abolish epicardial LAVAs in arrhythmogenic cardiomyopathy: A case report.

Elbatran AI, Li A, Saba MM.

J Cardiovasc Electrophysiol. 2019 Sep 19. doi: 10.1111/jce.14187. [Epub ahead of print] No abstract available.

PMID:
31535748
2.

Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.

Mathew S, Saguner AM, Schenker N, Kaiser L, Zhang P, Yashuiro Y, Lemes C, Fink T, Maurer T, Santoro F, Wohlmuth P, Reißmann B, Heeger CH, Tilz R, Wissner E, Rillig A, Metzner A, Kuck KH, Ouyang F.

J Am Heart Assoc. 2019 Mar 5;8(5):e010365. doi: 10.1161/JAHA.118.010365.

3.

Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?

Müssigbrodt A, Efimova E, Knopp H, Bertagnolli L, Dagres N, Richter S, Husser D, Bollmann A, Hindricks G, Arya A.

J Interv Card Electrophysiol. 2017 Mar;48(2):193-199. doi: 10.1007/s10840-016-0209-3. Epub 2016 Nov 30.

PMID:
27900527
4.

Role of high-resolution image integration to visualize left phrenic nerve and coronary arteries during epicardial ventricular tachycardia ablation.

Yamashita S, Sacher F, Mahida S, Berte B, Lim HS, Komatsu Y, Amraoui S, Denis A, Derval N, Laurent F, Montaudon M, Hocini M, Haïssaguerre M, Jaïs P, Cochet H.

Circ Arrhythm Electrophysiol. 2015 Apr;8(2):371-80. doi: 10.1161/CIRCEP.114.002420. Epub 2015 Feb 21.

PMID:
25713213
5.

Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE.

Circulation. 2009 Aug 4;120(5):366-75. doi: 10.1161/CIRCULATIONAHA.108.834903. Epub 2009 Jul 20. Erratum in: Circulation. 2010 Jun 1;121(21):e424.

PMID:
19620503
6.

Epicardial Ablation of Ventricular Tachycardia.

Tung R, Shivkumar K.

Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):129-34. doi: 10.14797/mdcj-11-2-129. Review.

7.

Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.

Komatsu Y, Daly M, Sacher F, Cochet H, Denis A, Derval N, Jesel L, Zellerhoff S, Lim HS, Jadidi A, Nault I, Shah A, Roten L, Pascale P, Scherr D, Aurillac-Lavignolle V, Hocini M, Haïssaguerre M, Jaïs P.

J Am Coll Cardiol. 2014 Apr 15;63(14):1416-26. doi: 10.1016/j.jacc.2013.10.087. Epub 2014 Jan 30.

8.

Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.

Kirubakaran S, Bisceglia C, Silberbauer J, Oloriz T, Santagostino G, Yamase M, Maccabelli G, Trevisi N, Della Bella P.

Europace. 2017 Jun 1;19(6):1049-1062. doi: 10.1093/europace/euw062.

PMID:
28371837
9.

Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

Santangeli P, Zado ES, Supple GE, Haqqani HM, Garcia FC, Tschabrunn CM, Callans DJ, Lin D, Dixit S, Hutchinson MD, Riley MP, Marchlinski FE.

Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1413-21. doi: 10.1161/CIRCEP.115.003562. Epub 2015 Nov 6.

PMID:
26546346
10.

Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.

Bai R, Di Biase L, Shivkumar K, Mohanty P, Tung R, Santangeli P, Saenz LC, Vacca M, Verma A, Khaykin Y, Mohanty S, Burkhardt JD, Hongo R, Beheiry S, Dello Russo A, Casella M, Pelargonio G, Santarelli P, Sanchez J, Tondo C, Natale A.

Circ Arrhythm Electrophysiol. 2011 Aug;4(4):478-85. doi: 10.1161/CIRCEP.111.963066. Epub 2011 Jun 10.

PMID:
21665983
11.

Utility of ripple mapping for identification of slow conduction channels during ventricular tachycardia ablation in the setting of arrhythmogenic right ventricular cardiomyopathy.

Xie S, Kubala M, Liang JJ, Yang J, Desjardins B, Santangeli P, van der Geest RJ, Schaller R, Riley M, Supple G, Frankel DS, Callans D, Pac EZ, Marchlinski F, Nazarian S.

J Cardiovasc Electrophysiol. 2019 Mar;30(3):366-373. doi: 10.1111/jce.13819. Epub 2019 Jan 6.

PMID:
30575168
12.

Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia.

Pathak RK, Garcia FC.

Card Electrophysiol Clin. 2017 Mar;9(1):99-106. doi: 10.1016/j.ccep.2016.10.007. Epub 2016 Dec 27. Review.

PMID:
28167090
13.

Endo-epicardial vs endocardial-only catheter ablation of ventricular tachycardia: A meta-analysis.

Cardoso R, Assis FR, D'Avila A.

J Cardiovasc Electrophysiol. 2019 Sep;30(9):1537-1548. doi: 10.1111/jce.14013. Epub 2019 Jul 2.

PMID:
31172632
14.

Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Philips B, te Riele AS, Sawant A, Kareddy V, James CA, Murray B, Tichnell C, Kassamali B, Nazarian S, Judge DP, Calkins H, Tandri H.

Heart Rhythm. 2015 Apr;12(4):716-25. doi: 10.1016/j.hrthm.2014.12.018. Epub 2014 Dec 18.

PMID:
25530221
15.

Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia.

Pokushalov E, Romanov A, Turov A, Artyomenko S, Shirokova N, Karaskov A.

Heart Rhythm. 2010 Oct;7(10):1406-10. doi: 10.1016/j.hrthm.2010.06.020. Epub 2010 Jun 17.

PMID:
20601157
16.

Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

Zghaib T, Ghasabeh MA, Assis FR, Chrispin J, Keramati A, Misra S, Berger R, Calkins H, Kamel I, Nazarian S, Zimmerman S, Tandri H.

Circ Cardiovasc Imaging. 2018 Sep;11(9):e007546. doi: 10.1161/CIRCIMAGING.118.007546.

17.

Unipolar peak-negative voltage as an endocardial electrographic characteristic to predict overlying abnormal epicardial substrates in patients with right epicardial ventricular tachycardia.

Chi PC, Lin YJ, Chang SL, Lo LW, Hu YF, Chao TF, Chung FP, Liao J, Tuan TC, Kuo JY, Huang JL, Chen SA.

J Cardiovasc Electrophysiol. 2014 Dec;25(12):1343-9. doi: 10.1111/jce.12495. Epub 2014 Aug 22.

PMID:
25066314
18.

Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation?

Schmidt B, Chun KR, Baensch D, Antz M, Koektuerk B, Tilz RR, Metzner A, Ouyang F, Kuck KH.

Heart Rhythm. 2010 Dec;7(12):1746-52. doi: 10.1016/j.hrthm.2010.08.010. Epub 2010 Aug 13.

PMID:
20709191
19.

Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study.

Berruezo A, Acosta J, Fernández-Armenta J, Pedrote A, Barrera A, Arana-Rueda E, Bodegas AI, Anguera I, Tercedor L, Penela D, Andreu D, Perea RJ, Prat-González S, Mont L.

Europace. 2017 Apr 1;19(4):607-616. doi: 10.1093/europace/euw212.

PMID:
28431051
20.

Correlation of right ventricular multielectrode endocardial unipolar mapping and epicardial scar.

Chrispin J, Keramati AR, Assis FR, Misra S, Zghaib T, Berger RD, Calkins H, Tandri H.

Pacing Clin Electrophysiol. 2018 Apr;41(4):345-352. doi: 10.1111/pace.13299. Epub 2018 Mar 12.

PMID:
29405366

Supplemental Content

Support Center